References
- Aoki Y, Sasaki M, Watanabe M, et al (2000). High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecologic Oncology, 77, 305-09. https://doi.org/10.1006/gyno.2000.5788
- Ayhan A1, Al RA, Baykal C, et al (2004). A comparison of prognoses of figo stage ib adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer, 14, 279-85. https://doi.org/10.1111/j.1048-891X.2004.014211.x
- Baalbergen A, Veenstra Y, Stalpers L (2013). Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev, 1, 6248.
- Chen YL, Ho CM, Chen CA, et al (2011). Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma. Int J Gynaecol Obstet, 112, 135-9. https://doi.org/10.1016/j.ijgo.2010.08.016
- Eifel PJ, Burke TW, Morris M, Smith TL (1995). Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol, 59, 38-44. https://doi.org/10.1006/gyno.1995.1265
- Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L (1990). Adenocarcinoma of the uterine cervix. prognosis and patterns of failure in 367 cases. Cancer, 65, 2507-14. https://doi.org/10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-9
- Fregnani JH, Soares FA, Novik PR, Lopes A, Latorre MR (2008). Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol, 136, 215-23. https://doi.org/10.1016/j.ejogrb.2006.10.021
- Gien LT, Beauchemin MC, Thomas G (2010). Adenocarcinoma: a unique cervical cancer. Gynecol Oncol, 116, 140-6. https://doi.org/10.1016/j.ygyno.2009.09.040
- Hopkins MP, Morley GW (1991). A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstetrics Gynecol, 77, 912-7.
- Huang YT, Wang CC, Tsai CS, et al (2012). Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys, 84, 420-7. https://doi.org/10.1016/j.ijrobp.2011.12.013
- Intaraphet S, Kasatpibal N, Siriaunkgul S, et al (2013). Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma. Asian Pac J Cancer Prev, 14, 5355-60. https://doi.org/10.7314/APJCP.2013.14.9.5355
- Irie T, Kigawa J, Minagawa Y, et al (2000). Prognosis and clinicopathological characteristics of ib-iib adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol, 26, 464-7. https://doi.org/10.1053/ejso.1999.0923
- Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S (2009). Radical hysterectomy for figo stage iib cervical cancer: clinicopathological characteristics and prognostic evaluation. Gynecol Oncol, 114, 69-74. https://doi.org/10.1016/j.ygyno.2009.03.026
- Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S (2012). Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol, 125, 292-6. https://doi.org/10.1016/j.ygyno.2012.01.034
- Kleine W, Rau K, Schwoeorer D, Pfleiderer A (1989). Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol, 35, 145-9. https://doi.org/10.1016/0090-8258(89)90032-2
- Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40. https://doi.org/10.1016/S0140-6736(97)02250-2
- Lee KB, Lee JM, Park CY, et al (2006). What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? a matched case-control study. Int J Gynecol Cancer, 16, 1569-73. https://doi.org/10.1111/j.1525-1438.2006.00628.x
- Lee YY, Choi CH, Kim TJ, et al (2011). A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. Gynecol Oncol, 120, 439-43. https://doi.org/10.1016/j.ygyno.2010.11.022
- Liu S, Semenciw R, Mao Y (2001). Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ, 164, 1151-2.
- Look KY, Brunetto VL, Clarke-Pearson DL, et al (1996). An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol, 63, 304-11. https://doi.org/10.1006/gyno.1996.0327
- Monk BJ, Tewari KS, Koh WJ (2007). Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol, 25, 2952-65. https://doi.org/10.1200/JCO.2007.10.8324
- Nakanishi T, Ishikawa H, Suzuki Y, et al (2000). A comparison of prognoses of pathologic stage IB adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 79, 289-93. https://doi.org/10.1006/gyno.2000.5935
- Peters RK, Chao A, Mack TM, et al (1986). Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst, 76, 423-8.
- Sherman ME, Wang SS, Carreon J, Devesa SS (2005). Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer, 103, 1258-64. https://doi.org/10.1002/cncr.20877
- Shingleton HM, Bell MC, Fremgen A, et al (1995). Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer, 76, 1948-55. https://doi.org/10.1002/1097-0142(19951115)76:10+<1948::AID-CNCR2820761311>3.0.CO;2-T
- Smith HO, Tiffany MF, Qualls CR and Key CR. (2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study. Gynecol Oncol, 78, 97-105. https://doi.org/10.1006/gyno.2000.5826
- Trattner M, Graf AH, Lax S, et al (2001). Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol, 82, 11-6. https://doi.org/10.1006/gyno.2001.6252
- Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E (2004). Increasing trends of cervical adenocarcinoma incidence in central Italy despite extensive screening programme, 1985- 2000. Cancer Detect Prev, 28, 461-4. https://doi.org/10.1016/j.cdp.2004.07.007
- Vizcaino AP, Moreno V, Bosch FX, et al (1998). International trends in the incidence of cervical cancer: I. adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer, 75, 536-45. https://doi.org/10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U
- Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100, 1035-44. https://doi.org/10.1002/cncr.20064
- Xie XZ, Song K, Cui B, et al (2012). Clinical and pathological factors related to the prognosis of Chinese patients with stage Ib to IIb cervical cancer. Asian Pac J Cancer Prev, 13, 5505-10. https://doi.org/10.7314/APJCP.2012.13.11.5505
Cited by
- Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon vol.12, pp.11, 2017, https://doi.org/10.1371/journal.pone.0187579
- Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis vol.143, pp.1, 2017, https://doi.org/10.1007/s00432-016-2246-9
- Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors vol.2017, pp.2314-6141, 2017, https://doi.org/10.1155/2017/2917925
- Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-5007-0
- Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer pp.1473-4877, 2019, https://doi.org/10.1080/03007995.2018.1502166